Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC47H61N7O6S |
InChIKeyINXGMIWEZJNJOA-NVZKIFIHSA-N |
CAS Registry2596365-98-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | United States | 25 Aug 2020 |





